248 related articles for article (PubMed ID: 13364530)
1. Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuromuscular transmission.
GROB D; HARVEY AM; JOHNS RJ
Bull Johns Hopkins Hosp; 1956 Sep; 99(3):153-81. PubMed ID: 13364530
[No Abstract] [Full Text] [Related]
2. Studies in neuromuscular function. III. Stimulating and depressant effects of acetylcholine and choline in normal subjects.
GROB D; HARVEY AM; JOHNS RJ
Bull Johns Hopkins Hosp; 1956 Sep; 99(3):136-52. PubMed ID: 13364529
[No Abstract] [Full Text] [Related]
3. Alterations in neuromuscular transmission in myasthenia gravis as determined by studies of drug action.
GROB D; JOHNS RJ; HARVEY AM
Am J Med; 1955 Nov; 19(5):684-90. PubMed ID: 13268464
[No Abstract] [Full Text] [Related]
4. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis.
GROB D; HARVEY AM; JOHNS RJ
Bull Johns Hopkins Hosp; 1956 Sep; 99(3):125-35. PubMed ID: 13364528
[No Abstract] [Full Text] [Related]
5. A morphological explanation of the transmission defect in myasthenia gravis.
Simpson JA
Ann N Y Acad Sci; 1971 Sep; 183():241-7. PubMed ID: 4330761
[No Abstract] [Full Text] [Related]
6. Neuromuscular transmission in myasthenia gravis.
CHURCHILL-DAVIDSON HC; RICHARDSON AT
J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
[No Abstract] [Full Text] [Related]
7. Studies on myasthenia gravis; apparent curare-like effect of compounds that decrease acetylcholine synthesis.
TORDA C; WOLFF HG
Fed Proc; 1946; 5(1 Pt 2):208. PubMed ID: 21064457
[No Abstract] [Full Text] [Related]
8. THE CHEMICAL THEORY OF NEUROMUSCULAR TRANSMISSION AND SOME APPLICATIONS TO MYASTHENIA GRAVIS.
THESLEFF S
Rev Neuropsiquiatr; 1964 Sep; 27():209-23. PubMed ID: 14333863
[No Abstract] [Full Text] [Related]
9. Physiology of neuromuscular transmission.
Roberts DV; Wilson A
Physiotherapy; 1972 Aug; 58(8):277-9. PubMed ID: 4360596
[No Abstract] [Full Text] [Related]
10. Alterations in muscle tension without similar changes in electrical activity in patients with myasthenia gravis.
BOTELHO SY
J Clin Invest; 1955 Sep; 34(9):1403-9. PubMed ID: 13252087
[No Abstract] [Full Text] [Related]
11. Eaton-Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle.
Molenaar PC; Newsom-Davis J; Polak RL; Vincent A
Neurology; 1982 Sep; 32(9):1061-5. PubMed ID: 6287358
[TBL] [Abstract][Full Text] [Related]
12. Choline acetyltransferase in skeletal muscle from patients with myasthenia gravis.
Molenaar PC; Newsom-Davis J; Polak RL; Vincent A
J Neurochem; 1981 Nov; 37(5):1081-8. PubMed ID: 7299388
[TBL] [Abstract][Full Text] [Related]
13. Myasthenic syndrome: effect of choline, plasmapheresis and tests for circulating factor.
Kranz H; Caddy DJ; Williams AM; Gay W
J Neurol Neurosurg Psychiatry; 1980 Jun; 43(6):483-8. PubMed ID: 6110709
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular transmission in myasthenia gravis.
CHURCHILL-DAVIDSON HC; RICHARDSON AT
Am J Med; 1955 Nov; 19(5):691-2. PubMed ID: 13268465
[No Abstract] [Full Text] [Related]
15. [On the impaired neuromuscular transmission in myasthenia gravis].
Kruckenberg P; Pontzen W; Sandweg R; Bauer H
Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
[No Abstract] [Full Text] [Related]
16. Passive transfer of seronegative myasthenia gravis to mice.
Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
[TBL] [Abstract][Full Text] [Related]
17. Reduced acetylcholine receptors in myasthenia gravis.
Drachman DB; Fambrough DM; Satyamurti S
Trans Am Neurol Assoc; 1973; 98():93-5. PubMed ID: 4361781
[No Abstract] [Full Text] [Related]
18. Choline acetyltransferase and acetylcholinesterase. Their role in the causes of myasthenia gravis.
Gentner DR; Rosenberg RN
Arch Neurol; 1972 Dec; 27(6):521-5. PubMed ID: 4343459
[No Abstract] [Full Text] [Related]
19. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
20. [Myasthenia gravis. Etiopathogenesis].
Pérez Ramírez JL; Cornejo Barrera M; Pérez Mijares R
Rev Clin Esp; 1977 Jun; 145(6):401-6. PubMed ID: 302012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
